Testosterone Replacement Therapy for Women: What No One Tells You
Testosterone is the most abundant biologically active sex hormone in women — and one of the most overlooked.
Low testosterone in women shows up as low libido, fatigue, brain fog, and muscle loss — not just "getting older."
The evidence for testosterone therapy improving sexual function in women is strong — this isn't fringe medicine.
Female TRT uses doses 10-20 times lower than male protocols. The goal is restoration, not augmentation.
Delivery method matters: topical creams and low-dose injections offer better dose control than pellets for women.
There's no FDA-approved testosterone product for women in the U.S. — you need a clinician who knows the off-label evidence and will monitor your labs.
Testosterone often works best as part of a comprehensive hormone picture, not a standalone fix.
The Hormone Nobody Talks About (Until You Really Need It)
You've heard plenty about estrogen. You've probably heard about progesterone too, especially if you've been through perimenopause or had a conversation with a forward-thinking doctor. But testosterone? That's still treated like a men-only topic, even though women make it, need it, and — as it turns out — suffer real consequences when they don't have enough of it.
The irony is hard to miss. Testosterone is actually the most abundant biologically active sex hormone in women across the entire lifespan. More abundant than estradiol. More abundant than progesterone. It just peaks at lower absolute levels than in men, which has led decades of medicine to more or less ignore it when it comes to women's health. That's starting to change, but slowly — and in the meantime, a lot of women are quietly dealing with low libido, crushing fatigue, mood changes, and muscle loss that no one has connected the dots on.
This is the article that connects the dots. You'll get a clear picture of why women need testosterone, what low levels actually feel like, how testosterone replacement therapy for women differs from male protocols, what the evidence shows, and what it looks like to actually try it under clinical supervision.
What Is Testosterone Replacement Therapy for Women, Really?
Testosterone replacement therapy (TRT) for women is exactly what it sounds like: restoring testosterone to a physiologically normal range when your levels have dropped below what your body needs to function well. The goal isn't to push your levels into a male range. It's to bring you back to where you were in your late 20s or early 30s, when most women feel their hormonal best.
Women produce testosterone primarily in the ovaries and adrenal glands. Levels peak in your mid-20s and then decline gradually — accelerating during perimenopause and dropping significantly post-menopause, when the ovaries scale back production dramatically. By the time most women are in their 50s, testosterone levels can be 50% or less of what they were at their peak.
Here's the thing that often surprises people: there's no FDA-approved testosterone product for women in the United States. Not one. That's not because testosterone doesn't work for women — the evidence says otherwise — it's a regulatory and commercial gap that leaves most conventional doctors shrugging. Women who benefit from testosterone therapy are typically accessing it through compounding pharmacies, off-label prescribing, or telehealth longevity clinics that know the literature and how to use it responsibly.
Why Do Women Need Testosterone? The Mechanism, Simply Put
Testosterone is a signaling molecule. Think of it less like a fuel and more like a key that opens specific locks throughout your body. Those locks — androgen receptors — are found in your brain, your bones, your muscles, your skin, your heart, and your reproductive tissue. When the key is missing, those locks stay closed.
In the brain, testosterone influences dopamine signaling (your motivation and reward system), which is a big part of why low testosterone often shows up as flat affect, diminished drive, and reduced libido. In muscle tissue, it stimulates protein synthesis, meaning your ability to build and maintain lean mass depends partly on it. In bone, it works alongside estradiol to maintain density. In the cardiovascular system, it plays a role in vascular tone and red blood cell production.
Testosterone also converts to estradiol through a process called aromatization, meaning some of its effects in women are actually downstream estrogen effects. This is one reason the relationship between testosterone and estrogen in women is more intertwined than simple hormone charts make it look. You can't fully optimize female hormone health by only looking at one of them.
Here's the catch: because testosterone touches so many systems, low levels rarely announce themselves with one obvious symptom. Instead, they tend to show up as a cluster of things you might attribute to stress, age, or not sleeping enough.
Signs You Might Have Low Testosterone
No single symptom is diagnostic on its own. But if several of these resonate, it's worth getting your levels checked:
- Low libido that feels different from before — not just reduced frequency, but a genuine absence of drive or desire
- Fatigue that isn't explained by sleep or thyroid issues, especially a kind of flat, motivational exhaustion
- Difficulty building muscle despite consistent training
- Mood changes including irritability, low mood, or a sense of emotional blunting
- Brain fog and reduced mental sharpness
- Loss of bone density, especially in postmenopausal women
- Reduced clitoral sensitivity or difficulty reaching orgasm
- Thinning hair and changes in skin texture
If you're postmenopausal, perimenopausal, or have had your ovaries removed surgically (which causes an immediate and dramatic drop in testosterone), these symptoms are especially worth paying attention to. But testosterone decline starts earlier than most women expect — often in the late 30s — and some women feel the effects well before formal menopause.
What the Evidence Actually Shows
Ready for some science that won't put you to sleep? The evidence base for testosterone in women is more robust than most doctors acknowledge, even if the mainstream hasn't fully caught up yet.
Libido and Sexual Function
This is the area with the strongest evidence. A landmark 2019 systematic review and meta-analysis published in The Lancet Diabetes & Endocrinology, covering 36 randomized controlled trials and over 8,000 women, found that testosterone therapy significantly improved sexual function — including desire, arousal, orgasm, and satisfaction — compared to placebo or estrogen alone. The effect sizes were clinically meaningful, not just statistically detectable. This is not a fringe finding — it's one of the most comprehensive reviews done on any aspect of women's hormone health.
Bone Density
Testosterone contributes to bone maintenance independently of estrogen, partly through direct androgen receptor action in bone cells and partly through its conversion to estradiol. Studies in postmenopausal women have shown that testosterone therapy, particularly via subcutaneous pellets or injections, is associated with increases in bone mineral density at the hip and spine — sites most relevant to fracture risk. This is particularly relevant for women who've had surgical menopause, where bone loss accelerates rapidly.
Muscle Mass and Physical Function
Testosterone is anabolic — it promotes muscle protein synthesis. In women, even the modest supraphysiologic doses sometimes used in studies have been associated with improved lean body mass and physical strength. A 2014 trial found that women receiving testosterone showed significant improvements in muscle mass and grip strength compared to controls. This matters more as you age: muscle mass is one of the strongest predictors of longevity and functional independence.
Mood, Cognition, and Energy
The evidence here is real but less definitive. Multiple studies report improvements in energy, well-being, and mood with testosterone therapy. The 2019 Lancet meta-analysis found positive effects on general well-being. Some smaller studies suggest neuroprotective effects and improved cognitive performance, particularly in women with surgical menopause. But large, long-term randomized controlled trials specifically on mood and cognition are still limited — this is an area to watch, not one to overstate.
The Reality Check: What We Don't Know Yet
The internet wants to sell you on testosterone as the missing piece of your health puzzle. The research is more nuanced than that.
Most of the high-quality studies on testosterone in women have been conducted in postmenopausal women. The evidence for premenopausal women is thinner. If you're in your late 30s and feeling off, testosterone might help — but "might" is doing real work in that sentence.
Long-term safety data, particularly for cardiovascular outcomes and breast cancer risk, are still limited. Current evidence does not suggest testosterone therapy increases breast cancer risk — in fact, some data suggest androgens may be protective — but this is not a settled question, and honest clinicians will say so. The same goes for cardiovascular effects: short-term data are reassuring, but long-term data in women are lacking.
And delivery method matters more than most people realize. Pellets, for example, produce much higher and less controllable testosterone levels than creams or injections — which is why some researchers and clinicians are skeptical of them despite their popularity. Dose control is everything in female TRT.
How Female TRT Differs From Male Protocols
This is worth being clear about, because conflating the two is where things go wrong.
Men's TRT targets testosterone levels in the range of 400-1000 ng/dL. Women's TRT targets a range closer to 15-80 ng/dL — roughly 10-20 times lower. The doses are correspondingly much smaller. A woman on testosterone therapy is not getting the same dose as a bodybuilder or even a male TRT patient. She's getting a careful, low-dose restoration to physiological female norms.
Delivery methods also differ. Pellets implanted under the skin are common in men's TRT and sometimes used in women, but the dose precision is poor — levels can spike unpredictably. For women, topical creams, gels, and low-dose injections offer better control and more predictable results.
Monitoring is critical. Because androgen receptors in women are more sensitive to testosterone, small changes in dose produce meaningful clinical effects — and side effects like acne, oily skin, hair thinning, or clitoral enlargement can occur even at modest supraphysiologic levels. Regular lab testing to keep levels in range isn't optional — it's the whole point.
Delivery Forms: Which One Is Right for You?
Topical Cream or Gel
Applied daily to the inner wrist, forearm, or inner thigh. Topical options provide steady, adjustable dosing and are easy to titrate. Absorption varies between individuals, which is why consistent application site and regular bloodwork matter. This is often the preferred starting point for women new to testosterone therapy because it offers the most flexibility.
Injections
Low-dose testosterone cypionate injections (typically weekly or twice weekly) provide consistent, predictable levels and are easy to monitor. Some women prefer injections because they remove the daily application variable. Dose precision is excellent.
Pellets
Subcutaneous pellets inserted every 3-6 months are convenient but less controllable. If your levels go too high, you can't dial them back — you wait. For women, where the therapeutic window is narrow, this is a meaningful limitation. Not recommended as a first-line approach.
Who Is Female TRT Actually Right For?
You're a good candidate for considering testosterone therapy if you're a woman who:
- Is perimenopausal or postmenopausal and experiencing low libido, fatigue, or muscle loss that isn't explained by other causes
- Has had a surgical oophorectomy (ovary removal), which causes immediate testosterone deficiency
- Is in your late 30s or 40s and noticing symptoms consistent with declining androgens, with labs to support it
- Has already optimized other hormones (estradiol, progesterone) and thyroid function — testosterone isn't a first step, it's part of a broader hormone picture
- Is committed to regular lab monitoring to ensure levels stay in a safe, physiological range
If you're primarily postmenopausal and your main concern is bone density, cardiovascular risk, or hot flashes, estradiol is still the first-line hormone to optimize. Testosterone works best as part of a comprehensive approach, not a standalone solution.
Risks and Side Effects
Testosterone therapy in women is generally well-tolerated at physiological doses, but side effects are real, dose-dependent, and worth knowing:
- Acne — particularly on the face, back, or chest
- Oily skin and hair
- Hair thinning or loss at the scalp (androgenic alopecia) in women who are genetically predisposed
- Clitoral enlargement — usually mild and often not bothersome, but dose-dependent
- Deepening of voice — rare at physiological doses, but possible if levels run high
- Elevated hematocrit (red blood cell count) — less common than in men, but monitored
- Acne at injection sites with injections
Most of these are reversible by reducing or stopping the dose. The key, again, is keeping levels in range through regular monitoring — which is exactly why supervised protocols exist.
How to Get Started With Testosterone Therapy Through Healthspan
Here's where the clinical reality matters: because there's no FDA-approved testosterone product for women in the U.S., you need a clinician who actually knows the off-label evidence, can prescribe through a compounding pharmacy, and will monitor your labs properly. That's not most primary care offices. It is what Healthspan is designed to do.
Healthspan offers several specific options for women who want to explore testosterone therapy under clinical supervision. Women's Hormone Health is the comprehensive starting point — it includes an initial consultation, a baseline hormone panel (total and free testosterone, SHBG, estradiol, progesterone, DHEA-S, and thyroid), clinical assessment of your symptoms, and a personalized prescription protocol if you're a candidate. Dosing, delivery form, and follow-up labs are all included. This isn't a one-time prescription — it's an ongoing clinical relationship with adjustments based on your real-world response.
For women who prefer topical delivery, Testosterone Topical Cream is available as a compounded, precisely dosed formulation. For those who want the consistency of injections, Testosterone Cypionate is offered with dosing calibrated to female physiological ranges — not male protocols. Both options include regular lab monitoring and clinical check-ins to make sure your levels stay where they should be.
If it turns out that testosterone is one piece of a broader hormone picture — which it often is — Healthspan also offers Estradiol Patch, Micronized Progesterone, and Bi-Est 50/50 Cream as part of a complete hormone optimization approach.
The right next step is simple: book a consultation, get your baseline labs, and have a real conversation with a clinician who can tell you whether testosterone therapy makes sense for you specifically.
Frequently Asked Questions
What are normal testosterone levels for women?
Normal total testosterone in women ranges from approximately 15 to 70 ng/dL, though labs may use slightly different reference ranges. Free testosterone (the biologically active fraction) is often more clinically relevant, especially if sex hormone binding globulin (SHBG) is elevated. A clinician should interpret your results in the context of your symptoms, not just the number in isolation.
How long does it take for testosterone therapy to work in women?
Most women notice initial changes within 4 to 8 weeks of starting therapy, particularly in libido and energy. Full effects — including improvements in muscle mass and bone density — typically take 3 to 6 months of consistent therapy. Levels should be checked at 6-8 weeks after starting or adjusting a dose to ensure you're in a physiological range.
Can testosterone therapy cause weight gain in women?
Testosterone is anabolic, meaning it promotes muscle building. Some women see a modest increase in scale weight that reflects lean mass gain, not fat gain — and body composition often improves (less fat, more muscle) even when weight stays similar. It does not cause the dramatic weight or fluid changes sometimes associated with estrogen therapy.
Is testosterone therapy safe for women with a history of breast cancer?
This is a nuanced question and not one to generalize. Current evidence does not show that testosterone therapy increases breast cancer risk, and some research suggests androgens may actually have a protective effect on breast tissue. However, women with hormone-receptor-positive breast cancer histories need individualized assessment. This is a conversation to have with both your oncologist and a hormone specialist.
Do I need to take estrogen and progesterone alongside testosterone?
Not necessarily, but it depends on where you are in the hormonal transition. Postmenopausal women who still have a uterus typically need progesterone alongside estrogen to protect the uterine lining. Testosterone can be used as a standalone therapy for specific symptoms like low libido, but a comprehensive hormone evaluation often reveals that optimizing estradiol and progesterone alongside testosterone produces better overall results.
What's the best delivery method for testosterone therapy in women?
Topical creams and gels are generally preferred as a starting point for women because they allow precise, adjustable dosing. Low-dose injections are another well-controlled option. Subcutaneous pellets are popular but offer less dose control — if levels run too high, you can't adjust quickly. The best delivery method depends on your lifestyle, preferences, and how your body absorbs and responds to each form.
Can younger women (30s and 40s) benefit from testosterone therapy?
Yes, in some cases. Testosterone declines gradually from the mid-20s onward, and some women in their late 30s and 40s experience meaningful symptoms of androgen deficiency before they're anywhere near menopause. Lab testing is essential to confirm whether levels are actually low, since symptoms can overlap with thyroid issues, iron deficiency, or other causes. When levels are genuinely suboptimal and symptoms are present, therapy can help.
- Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. doi:10.1016/S2213-8587(19)30189-5
- Davis SR, Wahlin-Jacobsen S. Testosterone in women — the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980-992. doi:10.1016/S2213-8587(15)00284-3
- Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847-3853. doi:10.1210/jc.2005-0212
- Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(10):3489-3510. doi:10.1210/jc.2014-2260
- Huang G, Basaria S, Travison TG, et al. Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause. 2014;21(6):612-623. doi:10.1097/GME.0000000000000093
- Glaser R, Dimitrakakis C. Testosterone therapy in women: myths and misconceptions. Maturitas. 2013;74(3):230-234. doi:10.1016/j.maturitas.2013.01.003
- Davis SR, Robinson PJ, Moufarege A, Bell RJ. The contribution of SHBG to the variation in androgen bioavailability is not amplified in women with HSDD. J Sex Med. 2012;9(3):793-800. doi:10.1111/j.1743-6109.2011.02630.x
- Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab. 2001;86(1):158-161. doi:10.1210/jcem.86.1.7138